Evonik Q3 2022 Earnings Conference Call

Volumes decline, pricing holding up: Double-digit price increases across all growth divisions
resulting in ongoing successful pass-on of higher variable costs.

Solid results in an increasingly challenging market environment:
Adj. EBITDA of €615 m in Q3 – supported by a strong Specialty Additives performance (+8% yoy).

Volumes decline; another +17% pricing on an already elevated prior-year basis.

Higher prices again compensate higher variable costs in all divisions.